Dorothee Semiond

Dorothee Semiond

UNVERIFIED PROFILE

Are you Dorothee Semiond?   Register this Author

Register author
Dorothee Semiond

Dorothee Semiond

Publications by authors named "Dorothee Semiond"

Are you Dorothee Semiond?   Register this Author

12Publications

295Reads

22Profile Views

Cabazitaxel is more active than first-generation taxanes in ABCB1(+) cell lines due to its reduced affinity for P-glycoprotein.

Cancer Chemother Pharmacol 2018 06 19;81(6):1095-1103. Epub 2018 Apr 19.

Division of Oncology, Department of Medicine, Stanford University School of Medicine, CCSR North 1120, 269 Campus Drive, Stanford, CA, 94305-5151, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-018-3572-1DOI Listing
June 2018

Preclinical profile of cabazitaxel.

Drug Des Devel Ther 2014 13;8:1851-67. Epub 2014 Oct 13.

Sanofi Oncology, Cambridge, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DDDT.S64940DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207555PMC
October 2015

A phase I open-label study investigating the disposition of [14C]-cabazitaxel in patients with advanced solid tumors.

Anticancer Drugs 2015 Mar;26(3):350-8

aSanofi R&D, Chilly-Mazarin bSanofi R&D, Vitry-sur-Seine, France cSanofi R&D, Cambridge, Massachusetts, USA dCharles River Biopharmaceutical Services, Tranent eEdinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000185DOI Listing
March 2015

Population pharmacokinetics of cabazitaxel in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2013 Mar 9;71(3):681-92. Epub 2013 Jan 9.

GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA 19406, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-012-2058-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579428PMC
March 2013